Treace Announces Interim 3-Year ALIGN3D™ Clinical Stu

PONTE VEDRA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical

Related Keywords

United States , Colorado , Americans , Johnt Treace , Triplanar Tarsometatarsal Arthrodesis , Julie Dewey , Twitter , American College Of Foot , Ankle Center , Company Mini , Exchange Commission , Instagram , Securities Exchange , Communications Investor Relations , Treace Medical Concepts Inc , Company Nasdaq , Linkedin , Facebook , Medical Concepts , Ankle Surgeons , Annual Scientific , Daniel Hatch , Board Member , Year Analyses , Early Weightbearing , Visual Analog Scale , Manchester Oxford Foot Questionnaire , Patient Outcomes Following , Mini Open Triplanar Tarsometatarsal Arthrodesis , Observer Scar Assessment Scale , Bunion Correction , Securities Act , Securities Exchange Act , Risk Factors , Annual Report , Midfoot Correction System , Rapid Compression Implants , Surgeon Advisory Board , Region ,